| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c405703ebb121bd634a5235e69c6525 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate |
2015-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90dd7f7dffa21f28f4cd045458525c68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae929496d9946e77100680ba66e34bf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7098736a597e72876efbaf54a31d01fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d71eba88849b91a75acda274d0fd41a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e8cb40dba7275ec54331188a5660045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a150f81b23db2c9f2b00598261f903f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22204d316835a88d4668997e233d3d18 |
| publicationDate |
2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017100421-A1 |
| titleOfInvention |
Compatible Composition Containing Chinese Medicine Cichorium Glandulosum Boiss Et Hout As Lipid-Lowering Active Ingredient |
| abstract |
Disclosed are a compound pharmaceutical composition containing Cichorium glandulosum Boiss et Hout as a lipid-lowering active ingredient and the use of the composition for preparing a drug for treating or preventing lipid metabolism disorders, wherein the composition comprises a pharmaceutically active ingredient and a pharmaceutically acceptable carrier, wherein the pharmaceutically active ingredient consists of quercetin-3-O-β-D-glucuronoside, isoquercitrin and quercetin at a molar ratio of 1.1-2.4:1.3-3.3:1.2-3.1. |
| priorityDate |
2014-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |